medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

An integrated framework for building trustworthy
data-driven epidemiological models: Application to the
COVID-19 outbreak in New York City
Sheng Zhang1* , Joan Ponce1* , Zhen Zhang2* , Guang Lin1,3# , George Karniadakis2
1 Department of Mathematics, Purdue University, West Lafayette, IN 47907, USA
2 Division of Applied Mathematics and School of Engineering, Brown University,
Providence, RI 02912, USA
3 School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA
* Equal contribution
# Corresponding author: Guang Lin (guanglin@purdue.edu)
Abstract: Epidemiological models can provide the dynamic evolution of a pandemic
but they are based on many assumptions and parameters that have to be adjusted over
the time when the pandemic lasts. However, often the available data are not sufficient
to identify the model parameters and hence infer the unobserved dynamics. Here, we
develop a general framework for building a trustworthy data-driven epidemiological
model, consisting of a workflow that integrates data acquisition and event timeline,
model development, identifiability analysis, sensitivity analysis, model calibration,
model robustness analysis, and forecasting with uncertainties in different scenarios. In
particular, we apply this framework to propose a modified
susceptibleâ€“exposedâ€“infectiousâ€“recovered (SEIR) model, including new compartments
and model vaccination in order to forecast the transmission dynamics of COVID-19 in
New York City (NYC). We find that we can uniquely estimate the model parameters
and accurately predict the daily new infection cases, hospitalizations, and deaths, in
agreement with the available data from NYCâ€™s governmentâ€™s website. In addition, we
employ the calibrated data-driven model to study the effects of vaccination and timing
of reopening indoor dining in NYC.

Introduction

1

This study aims to answer a fundamental question: given epidemiological data, how to
develop an appropriate model and identify which parameters we can accurately infer
that would, in turn, allow us to correctly predict the states of interest such as daily
cases, hospitalizations, and deaths. The objective of this work is to provide a systematic
way to model a pandemic accurately through carefully formulating a suitable model,
uniquely identifying the model parameters, and predicting outbreaks under
uncertainties based on the different epidemiological data available. To address the above
fundamental question, we propose a general integrated framework to approach the
problem systematically through identifiability analysis, sensitivity analysis, model
robustness analysis, and forecasting under uncertainties.
Numerous modeling approaches have been used to gain insight into epidemic
diseaseâ€™s ever-evolving dynamics and the effects the interventions have had on
containing the spread. Mathematical modeling is an efficient way to test and evaluate
the effectiveness of hypothetical interventions that cannot be tested out due to practical
or ethical limitations. Describing the diseaseâ€™s development involves representing a

February 10, 2021
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

1/39

2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

highly complex process affected by social, environmental, and biological factors.
Compartmental models have traditionally been used to depict systems that include
individuals with different health statuses that change in time. In particular,
mathematical modeling of COVID-19 using compartmental models described by
ordinary differential equations (ODEs) such as susceptibleâ€“infectiousâ€“recovered
(SIR) [1â€“3], modified SIR [1, 4â€“6], susceptibleâ€“exposedâ€“infectiousâ€“recovered (SEIR) [7â€“9]
and modified SEIR models [10, 11] has been used extensively in an attempt to capture
the virusâ€™ spread. These types of lumped mechanistic models, unlike data-driven models,
can explore future outcomes of the pandemic and evaluate the effects of various
interventions. Compartmental models are commonly applied in epidemiology for the
reason that they are simple and easily tractable. However, these models are local and
have limited capabilities to describe spatial dynamics. Partial differential equation
(PDE) models, such as diffusionâ€“reaction models, describe dynamics in time and space
more naturally [12, 13]. ODE models are the most commonly used models due to the
increased mathematical complexity and computational cost of PDE models. However,
their accuracy is constrained by parameter uncertainties and gaps in information about
the disease dynamics. Likewise, assumptions to maintain model simplicity may affect
the estimated values. For a long-lasting pandemic, the model parameters change with
time; hence the parameter identification problem becomes nontrivial given the fact that
typically a limited amount of relevant data is available.
In an ODE-based epidemiological model, the system parameters usually contain
critical information that often cannot be measured directly such as the transmission rate
which needs to be inferred from data. A necessary condition for the well-posedness of a
parameter estimation problem in ODE theory is the modelâ€™s structural identifiability if
we assume noise-free data. The structural identifiability analysis can be performed
without any experimental data; it addresses whether the parameter estimation problem
is well-posed under ideal conditions. Should the postulated model not be structurally
identifiable, the parameters obtained will be unreliable. However, a model can be
structurally identifiable (a necessary condition) but may not be practically identifiable.
Thus, the structural identifiability analysis may conclude that a modelâ€™s parameters are
uniquely determined, yet when real-life, noisy data are used, the estimated parameter
values could still be unreliable. To conduct the practical identifiability analysis, we
compute the correlation matrices of model parameters in different settings using Fisher
Information Matrices (FIMs) following lines of approach in [14, 15].
Non-identifiability is a problem frequently encountered in pandemics modeling since,
typically, not every state variable is available. In recent literature, model identifiability
issues have been studied due to the wide variation in model predictions in the context of
the COVID-19 pandemic [2, 16â€“18]. Tuncer et al. analyzed the structural and practical
identifiability of some of the most widely-used pandemic models, including SIR, SIR
with treatment, and SEIR, assuming only one observable is available using simulated
data [19]. Roda et al. extended these ideas by studying SIR and SEIR modelsâ€™ practical
identifiability using data from the COVID-19 outbreak in Wuhan, using only the counts
of infected individuals as the available data [2]. They found that complex mechanistic
models are more likely to have identifiability issues compared to simpler models.
Massoni et al. provided a systematical structural identifiability and observability
analysis of 255 available compartmental models for COVID-19 and found that
approximately one-third of them have structurally non-identifiable parameters [16].
Therefore, an identifiability test should be conducted as a sanity check when a new
ODE-based mechanistic model is proposed, to ensure trustworthy parameter estimation.
Furthermore, precise estimates of parameters allow us to determine an
epidemiologically relevant value called the basic reproduction number, R0 . The basic
reproduction number is defined as the average number of infections caused by one

February 10, 2021

2/39

17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

infected individual in an entirely susceptible population when disease control is absent,
and it determines whether a disease will persist or not in a population.
Still, uncertainty about parameter values could be relatively high at the beginning of
an outbreak even if identifiability is guaranteed. Therefore, determining the response of
a modelâ€™s output to parameter variation helps identify sources of uncertainty.
Sensitivity analysis studies how the uncertainty in the modelâ€™s output can be allocated
to different inputsâ€™ uncertainty sources [20]. It allows a better understanding of the
model to analyze how the model parameters affect the output.
In the present work, we propose to integrate these steps of identifiability and
sensitivity analysis together with policy change timelines, data availability, and
uncertainties in forecasting. We apply the proposed general framework to introduce a
modified SEIR model, which we extend to include vaccination, and forecast the
transmission dynamics of COVID-19 in New York City (NYC) under vaccination and
different safety measures relaxation scenarios. Daily cases, hospitalizations, and deaths
in NYC are used to demonstrate the way to employ the proposed framework for
simulating the ongoing COVID-19 pandemic in the city from early 2020 until February
2021.
COVID-19, which emerged in China in late 2019, has caused an outbreak affecting
over 200 countries worldwide and was declared a pandemic on March 11, 2020 [21] by
the World Health Organization. The strategies to control the spread of the virus in 2020
(before a vaccine was available) were mainly directed towards non-pharmaceutical
interventions, such as isolation of infected individuals, social distancing, and face-mask
use. COVID-19 was detected in a patient in NYC in early 2020 [22, 23]. The high
population density and lack of control measures in the first three weeks produced an
exponential increase in cases, which exceeded 20,000 before the statewide stay-at-home
order was put in place on March 22, 2020 [24]. Between March 22, 2020, and June 8,
2020, a host of social distancing measures and non-essential businesses closings in NYC
lowered the incidence from almost 2000 people infected a day in April to a couple of
hundred cases by June 8, 2020 [25]. The cityâ€™s first phase of its four-phase reopening
plan began on June 8, 2020, and the final stage started on July 20, 2020.
The proposed model considers presymptomatic, asymptomatic, hospitalized, isolated,
and deceased individuals. Structural identifiability, practical identifiability, and
sensitivity of the model are studied. Once the parameters that can be reliably estimated
are identified, the parameter estimation portion of the study is broached. Then, the
NYC outbreak data (daily infected, hospitalized, and deceased individuals) are employed
to estimate the model parameters to understand how public policy such as isolation,
public closings, and other social distancing measures impact the transmission dynamics.
Moreover, confidence intervals are computed, and the modelâ€™s predictive capabilities are
analyzed by considering the uncertainty of policies in constant flux. Next, we further
investigate model robustness. The main modeling assumption is that the transmission
rate is changing in time, following different policy measures, in a piecewise fashion. The
vaccination deployment in NYC is incorporated into the model, and we evaluate the
combined effect of vaccination and the gradual reopening process currently underway.
The novelty of this work is multi-fold:
â€¢ We develop a general framework and workflow for building a trustworthy
data-driven epidemiological model;

70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112

113
114

â€¢ We propose a modified SEIR model with vaccination and validate it with the
pandemic data in New York City (daily cases, hospitalizations, and deaths); every
parameter in our model has physical meaning;
â€¢ We systematically study the structural identifiability, practical identifiability, and
sensitivity to examine the relationship between the model dynamics, data, and

February 10, 2021

69

3/39

115
116
117

118
119

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Unique parameters

Prediction only
no

(I)

(II)

Data acquisition
and event
timeline

Epidemiological
COVID-19
model
model
development
development

(III)
Identifiability
analysis

Identifiable?

yes

(IV)
Sensitivity
analysis

no
(VII)
Forecasting with
uncertainties
and scenarios

(VI)

yes
MSARE<1?

Model
robustness
analysis

(V)
Model
calibration

Fig 1. A general framework for building a trustworthy data-driven epidemiological model â€” an overview of
the main contribution. In this work, we propose a general framework for building a trustworthy data-driven
epidemiological model, which constructs a workflow to integrate data acquisition and event timeline, model development,
identifiability analysis, sensitivity analysis, model calibration, model robustness analysis, and forecasting with uncertainties
and scenarios. We first introduce a modified SEIR model that accommodates the pandemic data in New York City. Secondly,
we study the structural identifiability, practical identifiability, and sensitivity to examine the relationship between the modelâ€™s
data and parameters. We then calibrate the identifiable model parameters using simulated annealing and MCMC simulation.
Model robustness is then checked to study how the model behaves under random perturbations. In addition, we demonstrate
the modelâ€™s predictive capabilities with uncertainties. Finally, reopening scenarios are investigated as a reference for
policymakers.
parameters;

120

â€¢ We treat the transmission rate, hospitalization ratio, and death from hospital
ratio as time-dependent model parameters based on the event-timeline, and
calibrate the identifiable model parameters using simulated annealing and MCMC
simulations. We also investigate model robustness by studying how the model
behaves under random perturbations;
â€¢ We demonstrate the modelâ€™s predictive capabilities under uncertainties for
different future scenarios;

122
123
124
125

126
127

â€¢ We specifically investigate the effects of indoor dining reopening and vaccination
scenarios as a reference for policymakers.

General Framework and Workflow

128
129

130

Holmdahl and Buckee, in [26], discussed different types of models for the COVID-19
epidemic as well as the distinct challenges in these approaches. The authors highlighted
that â€œmodels are a way to formalize what we know about the viral transmission and
explore possible futures of a system that involves nonlinear interactions, something that
is almost impossible to do using intuition alone.â€ They further elaborate that â€œmodels
will be useful for exploring possibilities rather than making strong predictions about
longer-term disease dynamics.â€ Thus, a systematic way of designing an effective
data-driven model is essential for assessing ongoing control strategies endowed with
uncertainty quantification.
To systematically design an effective data-driven model, we propose a general
framework for building a trustworthy data-driven epidemiological model, which

February 10, 2021

121

4/39

131
132
133
134
135
136
137
138
139
140
141

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

constructs a workflow to integrate data acquisition and event timeline, model
development, identifiability analysis, sensitivity analysis, model calibration, model
robustness analysis, model prediction with uncertainties and investigation of reopening
scenarios together. Fig 1 gives an overview of the framework, with details for each stage
provided below.
(I) Acquire data and look for major interventions or events that could affect the
transmission dynamics of the epidemic.
(II) Develop an epidemiological model that accommodates the data and events in
(I). The intervention events can be encoded through time-dependent parameters in the
model.
(III) Use both structural and practical identifiability analysis to determine the
parameters to fit. Domain knowledge can also be incorporated in this step to help
choose the parameters. If the model is not identifiable but one prefers unique
parameters, one should fix some of the non-identifiable parameters in the model or
propose other models. Otherwise, one can proceed to (IV).
(IV) Conduct sensitivity analysis to find the most sensitive parameters to each
observable. In cases when an observable is insensitive to a parameter, even if the
parameter is non-identifiable, one can still use the model to calibrate that observable.
(V) Calibrate the most sensitive and identifiable model parameters. Estimate the
model compartments and the reproduction number.
(VI) Check model robustness assuming different types of noise in the data. Justify
model predictions with the support of sensitivity analysis results. If the model is robust
to noise, then one can proceed to (VII), otherwise one should go back to (II) and fix
some model parameters or employ other models.
(VII) Predict the future development of the epidemic with uncertainties assuming
the current control measures. Then investigate how policy changes could influence the
transmission dynamics of the epidemic.
We evaluate the effectiveness of the proposed framework by applying all the outlined
steps to the outbreak dataset in NYC. One of the advantages of the frameworkâ€™s
generality is that it is not limited to a single dataset or model. In general, it provides a
guideline on how to build an effective and trustworthy epidemiological model with the
available data. For illustration purposes, we show how our framework can handle
different data types by assuming scenarios when some observables in the NYC dataset
are missing. However, for practical use, one should determine the data that are fed to
the model at the very beginning.

(I) Data acquisition and event timeline

143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176

177

We use the data consisting of daily cases, hospitalizations, and deaths between February
29, 2020, and February 4, 2021, to fit the modelâ€™s parameters. All the data used in this
paper were extracted from the NYCâ€™s governmentâ€™s website and collected by the NYC
Health Department [25]. Hospitalization data were collected from several sources, such
as NYC public hospitals, non-public hospitals, and the Health Departmentâ€™s syndromic
surveillance database, which track hospital admissions across NYC. The data on the
NYC online repository [25] is published by the date of the event, rather than the date of
the report. A person is classified as a confirmed COVID-19 case when they test positive
in a molecular test (PCR). A deceased individual is classified as a disease-related death
if they were an NYC resident who had a positive PCR test for the virus within the last
60 days.
Since the first case of COVID-19 was reported in NYC on February 29, 2020, local
authorities have implemented several non-pharmaceutical interventions, such as social
distancing and mask-wearing [24, 25]. These restrictions were later relaxed as the

February 10, 2021

142

5/39

178
179
180
181
182
183
184
185
186
187
188
189
190
191

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 2. COVID-19 epidemic in New York City: data and event timeline. (a) Daily infectious population (February
29, 2020 â€“ February 4, 2021). We split the data into seven time periods based on interventions implemented. The starting
times of interventions are shown on the top of each subfigure. (b) Daily hospitalized population (February 29, 2020 â€“
February 4, 2021). (c) Daily deceased population. (February 29, 2020 â€“ February 4, 2021). (d) Daily vaccinated population.
(December 14, 2020 â€“ February 4, 2021).

incidence decreased. Any control measures implemented will have an impact on the
transmission term Î². Thus, we identified seven time periods defined based on the
interventions implemented (also see Fig 2):
â€¢ Stage 1 (no control): February 29, 2020 â€“ March 22, 2020

193
194

195

The New York State governor declared a state of emergency on March 7, 2020,
after 89 positive cases were identified [27]. However, most businesses operated as
usual until March 14, 2020, when some public libraries closed. Nightclubs,
theaters, and concert venues followed suit on March 17, 2020.
â€¢ Stage 2 (stay-at-home order): March 22, 2020 â€“ April 17, 2020

196
197
198
199

200

A stay-at-home order (also known as PAUSE) issued by the New York Stateâ€™s
governorâ€™s office went into effect on March 22, 2020. The PAUSE plan comprised
a 10-point policy that mandated all non-essential businesses statewide to close,
cancel gatherings of any size, and businesses that provide essential services must
facilitate social distancing of at least six feet, among others. Schools and
universities closed and moved to remote instruction.
â€¢ Stage 3 (mask mandate): April 17, 2020 â€“ June 8, 2020

February 10, 2021

192

201
202
203
204
205
206

207

6/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

New York State was one of the first states to issue orders mandating face
coverings in public spaces [28]. This decision followed the Centers for Disease
Control and Prevention (CDC) guidelines, which encouraged people to wear
masks to prevent transmission of the virus through droplets generated when an
infected person coughs or sneezes [29].
â€¢ Stage 4 (four-phase reopening): June 8, 2020 â€“ September 30, 2020
The stay-at-home order was effective in bringing down the diseaseâ€™s incidence. As
a result, a four-phase reopening plan was developed, taking into account seven
health metrics the city needed to meet before reopening [30]. NYC entered Phase
1 of reopening on June 8, Phase 2 on June 22, Phase 3 on July 6, and Phase 4 on
July 20. Each phase had specific policies that determined what businesses could
reopen and in what capacity. Industries that posed the lowest risk of infection for
employees and customers were allowed to reopen in Phase 1. These included but
were not limited to construction, manufacturing, and wholesale supply-chain
businesses and retailers for curbside pickup, in-store pickup, or drop-off [31].
Phase 2 allowed offices, places of worship (25% capacity), finance and insurance,
administrative support, among others, to reopen if they follow established social
distancing guidelines [32]. In Phase 3, some personal services were allowed to
reopen; indoor dining was not allowed in NYC, even though this phase allowed
other areas of the state to enable indoor dining at a reduced capacity. NYC
entered reopening Phase 4 on July 20. Restrictions regarding group gatherings
were eased, and meetings of up to 50 people were allowed. Indoor religious
meetings were allowed to resume at 33% capacity. Malls, zoos, and botanical
gardens were also permitted to reopen in this phase. NYC stayed at Phase 4 until
September 30, 2020, when indoor dining at 25% capacity was allowed.
â€¢ Stage 5 (indoor dining reopens at reduced capacity): September 30,
2020 â€“ December 14, 2020
The careful reopening process, which followed the strict stay-at-home order,
maintained a low infection rate in the city (below 1%) [33]. NYC resumed indoor
dining services at 25% capacity on September 30, 2020, intending to double the
capacity if infection rates remained low. Restaurants were required to follow an
extensive set of rules upon reopening, such as temperature checks, contact tracing
reporting, mask usage except when seated, and a midnight curfew.
â€¢ Stage 6 (indoor dining closes and vaccination begins): December 14,
2020 â€“ January 6, 2021
In December 2020, the increasing rate of virus transmission in NYC threatened to
overwhelm hospital capacity. Although contact tracing data from NYC placed
indoor dining as the fifth source of new infections in the state, the CDC
designated indoor dining as a â€œhigh riskâ€ activity [34]. The governorâ€™s decision to
ban indoor dining was an attempt to halt the steep increase in cases and avoid a
broader shutdown. In the same week when the governorâ€™s office closed indoor
dining again, the first coronavirus vaccine was administered in Queens on
December 14, 2020 [35].
â€¢ Stage 7 (Christmas and New Year holiday ends): January 6, 2021 â€“
February 14, 2021
The increased social activities during Christmas and New Year celebrations had a
significant impact on the outbreakâ€™s spread. This final period is defined by an
event, the end of the holidays, and restaurantsâ€™ reopening in limited capacity
announced for February 14, 2021.

February 10, 2021

7/39

208
209
210
211
212

213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232

233
234
235
236
237
238
239
240

241
242
243
244
245
246
247
248
249
250

251
252
253
254
255
256

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Two shipments from drug companies Pfizer and Moderna aim to cover a quarter
of the estimated 1.8 million people deemed high priority to receive the vaccine in
the first phase of distribution in the state. However, even though vaccination
started on December 14, 2020, people vaccinated do not develop immunity to the
virus immediately. The Pfizer vaccineâ€™s first dose needs about 14 days to be 52%
effective. The second dose should be administered three weeks after the first dose.
The reported effectiveness of the Pfizer vaccine is 95%, while Moderna reports
94.1% [36, 37], if two doses are received. Itâ€™s worth noting that if a person only
receives one dose, its effectiveness varies depending on the company that produced
the vaccine. For example, the Pfizer-BioNTech vaccine is roughly 52% effective
after the first dose, while the Moderna vaccine can provide 80.2% protection after
one dose [36]. Atâ€“risk groups, such as older people in nursing homes and public
health professionals, are prioritized for vaccination in NYC in this first phase. We
use data reported by NYC Health, extracted from the Citywide Immunization
Registry (CIR). The data include the daily numbers of individuals who have
received the first and second dose [35]; see Fig 2.

(II) Epidemiological Model development

258
259
260
261
262
263
264
265
266
267
268
269
270
271
272

273

Classic SIR and SEIR models do not include the exposed and presymptomatic periods,
which play an important role in this particular disease. Recent studies have revealed the
role of asymptomatic [41â€“44] and presymptomatic individuals [45â€“47] in the diseaseâ€™s
transmission chain. Additionally, due to CDC recommendations, infected individuals
are required to self-isolate once they test positive for ten days [29]. Therefore, these
individuals are removed from the population until they are no longer infectious. We
include these individuals in the isolated compartment of our model. Therefore, to
account for the complete epidemiological characteristics of a COVID-19 infection, in this
model we modify an SEIR model to include presymptomatic, asymptomatic,
hospitalized, isolated, and deceased compartments; see Fig 3.
These modifications allow a more accurate description of the biology of the disease.
Since this study focuses on a single outbreak, births and other deaths are not
considered. When the epidemic begins, all individuals are susceptible and transit to the
exposed class via contact with presymptomatic, symptomatic, or asymptomatic
individuals. Moreover, we assume that there is no reinfection. In other words, once an
individual recovers, they do not become susceptible again. We divide the total
population into nine different compartments: susceptible (S), exposed (E),
presymptomatic infected (P ), symptomatic infected (I), asymptomatic infected (A),
hospitalized (H), isolated (Q), deceased (D), and recovered (R). The contribution to
the transmission of COVID-19 from asymptomatic individuals (A) relative to the
transmission from symptomatic individuals (I) is labeled . Therefore, if  = 0.75, this
means that an asymptomatic individual is 75% as infectious as an asymptomatic
individual. Similar to [39], we assume that presymptomatic individuals (P ) are just as
infectious as asymptomatic individuals (A). The transmission rate of the disease is
denoted by Î². After a latent period (1/dE ), an exposed individual becomes
presymptomatic infectious. A presymptomatic infectious individual develops symptoms
with probability Î´ or is asymptomatic with probability (1 âˆ’ Î´) after (1/dP ) days.
Asymptomatic individuals recover after an infective period of (1/dA ). A proportion p of
symptomatic individuals is hospitalized after an infective period of (1/dI ), while the
rest of them are isolated (for example, isolated at home) but do not go to the hospital.
The isolation period is (1/dQ ). The hospitalization period is (1/dH ), at the end of
which, a proportion q of the hospitalized individuals die while the rest of them recover.
Asymptomatic cases pose a challenge to identify since there is no widespread systematic

February 10, 2021

257

8/39

274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 3. Transition diagram between epidemiological classes. We modify the classic SEIR model to include
presymptomatic (P ), asymptomatic (A), hospitalized (H), isolated (Q), and deceased (D) individuals. The given data are the
inflows of symptomatic (I), hospitalized (H), and deceased (D) individuals. The parameters to estimate are (Î², p, q). See
Table 1 for the notations and the initial values. See Table 2 for the parameters. See Eq. (1) for the corresponding ODE
system.
Table 1. Notations and initial values for the model in Fig 3.
Notation

Meaning

Initial value

Note

N
S
E

Total population
Susceptible
Exposed

8399000
8398713
270

P

Presymptomatic

15

I
A
H
Q
D
R
Isum
Hsum
Dsum

Symptomatic
Asymptomatic
Hospitalized
Isolated
Deceased
Recovered
Cumulative cases
Cumulative hospitalizations
Cumulative deaths

1
1
0
0
0
0
1
0
0

We assume constant total population in NYC
S(0) = N âˆ’E(0)âˆ’P (0)âˆ’I(0)âˆ’A(0)âˆ’H(0)âˆ’Q(0)âˆ’D(0)âˆ’R(0)
E(0) = Eâˆ— /Î´, where Eâˆ— is the number of cases from day (2/dP +1)
to day (2/dP + 2/dE ) (Mar 6-10, 2020)
P (0) = Pâˆ— /Î´, where Pâˆ— is the number of cases from day 1 to
day 2/dP (Mar 1-5, 2020)
I(0) = 1 from data
A(0) = I(0) Ã— (1 âˆ’ Î´)/Î´ â‰ˆ 1
H(0) = 0 from data
Q(0) = 0
D(0) = 0 from data
R(0) = 0
Isum (0) = 1 from data
Hsum (0) = 0 from data
Dsum (0) = 0 from data

Table 2. Parameters for the model in Fig 3.
Parameter

Meaning

Calibration

Range/Value

Note

Î²
p
q

Î´
1/dE
1/dP
1/dI
1/dA
1/dH
1/dQ

Transmission rate
Hospitalization ratio
Death from hospital ratio
Infectivity ratio of asymptomatic to symptomatic
Proportion of symptomatic individuals
Latent period
Mean infectious period of P class
Mean infectious period of I class
Mean infectious period of A class
Mean duration of H class
Mean duration of Q class

fitted
fitted
fitted
fixed
fixed
fixed
fixed
fixed
fixed
fixed
fixed

[0, 1]
[0, 1]
[0, 1]
0.75
0.6
2.9 days
2.3 days
2.9 days
7 days
6.9 days
10 days

Fitted within wide range
By definition
By definition
Ref. [38]
Ref. [38]
Ref. [39]
Ref. [39]
Ref. [39]
Ref. [40]
Ref. [38]
Ref. [29]

February 10, 2021

9/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

testing of the population [41]. Thus, there is a wide range of estimates for the
proportion of symptomatic individuals Î´. In this study, we use the best estimate of Î´
provided by the CDC [38].
Moreover, the proposed model has considered the vaccination deployment in NYC
and the impact on the cityâ€™s daily cases, hospitalizations, and deaths. A susceptible
individual leaves the (S) class and joins the recovered individuals (R) once they are
effectively vaccinated, i.e., they are vaccinated and the vaccine prevents them from
getting the disease in the future. To calculate the number of effectively vaccinated
individuals that takes into account the vaccine efficacy, we use a weighted sum of the
number of the first doses and second doses administered. See Fig 3, where v is defined
as the daily number of effectively vaccinated individuals.
The ODE system for our model (see Fig 3) is the following:
ï£±
I + A + P
v
dS
ï£´
ï£´
= âˆ’Î²
Sâˆ’ S
ï£´
ï£´
dt
N
N
ï£´
ï£´
ï£´
ï£´
dE
I + A + P
ï£´
ï£´
=Î²
S âˆ’ dE E
ï£´
ï£´
dt
N
ï£´
ï£´
ï£´
ï£´
dP
ï£´
ï£´
= dE E âˆ’ dP P
ï£´
ï£´
ï£´
dt
ï£´
ï£´
ï£´
dI
ï£´
ï£´
= Î´dP P âˆ’ dI I
ï£´
ï£´
ï£´
dt
ï£´
ï£²
dA
(1)
= (1 âˆ’ Î´)dP P âˆ’ dA A
ï£´
dt
ï£´
ï£´
ï£´
ï£´
dH
ï£´
ï£´
= pdI I âˆ’ dH H
ï£´
ï£´
dt
ï£´
ï£´
ï£´
ï£´
dQ
ï£´
ï£´
= (1 âˆ’ p)dI I âˆ’ dQ Q
ï£´
ï£´
dt
ï£´
ï£´
ï£´
ï£´
dD
ï£´
ï£´
ï£´
ï£´ dt = qdH H
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³ dR = dA A + (1 âˆ’ q)dH H + dQ Q + v S.
dt
N
Note that the compartments (I, H, D) represent the current symptomatic
individuals, hospitalizations, and deaths. In order to represent the daily cases Inew ,
hospitalizations Hnew , and deaths Dnew , we add the following ODEs that take into
account the inflow of the these compartments to record the cumulative cases Isum ,
hospitalizations Hsum , and deaths Dsum :
ï£±
dIsum
ï£´
ï£´
ï£´ dt = Î´dP P
ï£´
ï£´
ï£²
dHsum
(2)
= pdI I
ï£´
dt
ï£´
ï£´
ï£´
ï£´
ï£³ dDsum = qd H.
H
dt
Now, the daily numbers are just the increments of the cumulative numbers:
ï£±
ï£´
ï£² Inew (t) = Isum (t) âˆ’ Isum (t âˆ’ 1)
Hnew (t) = Hsum (t) âˆ’ Hsum (t âˆ’ 1)
ï£´
ï£³
Dnew (t) = Dsum (t) âˆ’ Dsum (t âˆ’ 1)

308
309
310
311
312
313
314
315
316
317
318

319
320
321
322
323

324

(3)

for t = 1, 2, 3, Â· Â· Â· .

February 10, 2021

307

325

10/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Time-dependent model parameters (piecewise constant Î², p,
and q)
The transmission rate of a disease, Î², is the per capita rate of infection when a contact
occurs. Directly measuring the transmission rate is not possible for most infections [48].
Nevertheless, if we want to quantify the effects of public health policies that directly
impact the transmission rate, estimating this value accurately is critical. Moreover,
public health policy and the discovery of better therapies and treatments affect other
parameters besides the diseaseâ€™s transmission rate. Notably, the percentage of
disease-related deaths changes over the course of the outbreak [49]. Similarly, the
hospitalization ratio varies due to increased resources channeled to the healthcare
system in the city [25, 50]. Control measures implemented in NYC and the subsequent
relaxation of restrictions impact the incidence curve in different waysâ€”most of them
non-linear. Therefore, defining the transmission rate Î²(t) as a piecewise constant
function is a simplification that allows us to estimate the impact each policy has in each
stage. Similarly, we define the piecewise constant hospitalization ratio p(t) and death
from hospital ratio q(t), which also exhibit varying values over time:
ï£±
Î²1 , p1 , q1 t âˆˆ Stage 1
ï£´
ï£´
ï£´
ï£´
ï£´
Î²2 , p2 , q2 t âˆˆ Stage 2
ï£´
ï£´
ï£´
ï£´
ï£´
Î²
ï£´
ï£² 3 , p3 , q3 t âˆˆ Stage 3
Î²(t), p(t), q(t) = Î²4 , p4 , q4 t âˆˆ Stage 4
(4)
ï£´
ï£´
ï£´
Î²5 , p5 , q5 t âˆˆ Stage 5
ï£´
ï£´
ï£´
ï£´
ï£´
Î²6 , p6 , q6 t âˆˆ Stage 6
ï£´
ï£´
ï£´
ï£³
Î²7 , p7 , q7 t âˆˆ Stage 7.
We fit the parameters in each stage defined by policy changes, such as the stay-at-home
order and the subsequent reopening processes; see Fig 2.

Reproduction number

327

328
329
330
331
332
333
334
335
336
337
338
339
340
341

342
343

344

The basic (control) reproduction number, denoted by R0 (Rc ), is the average number of
secondary infections caused by one infected individual in an entirely susceptible
well-mixed population in the absence (presence) of disease control. The control
reproduction number of the model is:



Î´
(1 âˆ’ Î´)
Rc = Î²
+
+
.
(5)
dP
dI
dA
In this particular study, given that the model parameters are defined in a piecewise
fashion and there was no control in Stage 1, the basic reproduction number, R0 , is
computed by using Î² = Î²1 .
The transmission of the disease slows down when there are more immune individuals.
Since Rc is the number in an entirely susceptible population, we can calculate the
effective reproduction number:
S
Re = Rc Â· .
(6)
N
By setting Re = 1, we obtain the immunity threshold of the ODE system, which is the
critical portion of the population needed to be immune to stop the transmission of the
disease:
1
IT = 1 âˆ’
.
(7)
Rc
The herd immunity threshold (HIT) is calculated by substituting Rc with R0 . A higher
R0 results in a higher HIT.

February 10, 2021

326

11/39

345
346
347
348

349
350
351
352
353
354

355
356
357

358
359

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

(III) Identifiability analysis

360

In this section we address whether a set of unknown parameters in the proposed model
is globally identifiable from the available data. Fitting a model to the data is not
sufficient to show how reliable the estimated parameters are. Insufficient or noisy data
can produce drastically different sets of parameters without affecting the fit to data if a
model is non-identifiable [2]. Furthermore, depending on the available data
(observables), different models may be appropriate.
Formally speaking, a parameter in a dynamical system is considered to be
identifiable if the solutions can uniquely determine it. Two different types of
identifiability, namely structural and practical identifiability are considered in this
paper. Structural identifiability analysis studies the uniqueness of parameter values
from the perspective of the structure of the equation and is normally conducted before
the fitting of the model, thus commonly referred to as a priori identifiability. Global
(structural) identifiability provides conclusions about a parameterâ€™s identifiability in the
entire parameter space [51â€“54]. In particular, it guarantees the opportunity of uniquely
identifying the model parameters from the data [51â€“53, 55]. In some cases, however,
local structural identifiability may be sufficient, and hence the range of values of the
parameter to be identified should be limited. On the other hand, practical identifiability
analysis mainly addresses the issue of nonuniqueness when fitting the model on the
discrete data points, i.e., a posteriori. Structural identifiability does not imply practical
identifiability because of the amount and quality of the data. A detailed explanation of
these two types of identifiability can be found in S4 Text. We use the open-source
software SIAN [56] for structural identifiability and use correlation matrix calculated
from Fisher Information Matrix (FIM) for practical identifiability. Details of the
implementation can also be found in the supporting information.
In our framework, we analyze both structural and practical identifiability, and use
the results as guidelines for parameter selection. The importance of performing both
types of analysis resides in the fact that structural identifiability itself does not
guarantee the goodness-of-fit of the model. It turns out that in our case, fitting all
structural identifiable parameters would lead to practically non-identifiable results.

Structural identifiability

362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389

390

There are 11 undetermined parameters in the proposed model, and it is impossible to fit
every parameter without fixing some of the values. For example, it is unnecessary to fit
biologically determined parameters such as the time an individual spends in the exposed
or infected classes. Since dE , dP , dI , dA , dH , and dQ are determined by the biology of
the disease, we fix these values according to [39].
We analyze the structural identifiability of the rest of the parameters when different
types of data are given. Note that for general use of our modeling framework, one
should fix the dataset at step (I). Here we consider all the scenarios just for illustration
purpose. Specifically, we assume that the data are given as the cumulative cases Isum ,
cumulative hospitalizations Hsum , and cumulative deaths Dsum , or a subset of the three
aforementioned observables, because these quantities can be calculated directly from
daily quantities Inew , Hnew , and Dnew . In other words, it is equivalent to assume Xnew
or Xsum to be given as one of the observables, where X can be I, H, and D. The
effectively vaccinated population v is treated as the input variable to the system.
According to Table 3, when only two out of three observables are available, the model is
not identifiable and the fitting result will not be unique. The results are to be
interpreted in the following way. In the case of lacking deceased individual counts, the
death rate q cannot be inferred accurately. If the hospitalization data are not available,
both the hospitalization ratio p and death from hospital ratio q cannot be inferred

February 10, 2021

361

12/39

391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

(a)

(b)

Parameters
of interest

Biologically
determined

ð›½, ð‘, ð‘ž, ðœ–, ð›¿, ð‘‘! , ð‘‘" , ð‘‘# , ð‘‘$, ð‘‘% , ð‘‘&

ð›½, ð‘, ð‘ž, ðœ–, ð›¿

ilit
ifiab
t
n
Id e

y

ð›½, ð‘, ð‘ž

Fig 4. The procedure of choosing parameters to fit. (a) The procedure of determining parameters to fit. We fix dE ,
dP , dI , dA , dH , dQ because they are biologically determined, and then fix , Î´ due to the result from the correlation matrix
analysis. (b) The correlation matrix of five parameters. Each colored off-diagonal cell represents the correlation between two
parameters. Green means (almost) not statistically correlated while yellow/purple represents positively/negatively correlated,
respectively.

Table 3. Structural identifiability of Î², p, q, , Î´ with different observables. Global/not means structurally
globally/not identifiable, respectively. We fix all the rest of the parameters as in Table 2. It is necessary to include all three
observables to guarantee the structural identifiability of the model.
Parameter

Isum , Hsum , Dsum

Isum , Hsum

Isum , Dsum

Hsum , Dsum

Isum

Hsum

Dsum

Î²
p
q

Î´

global
global
global
global
global

global
global
not
global
global

global
not
not
global
global

not
not
global
global
global

global
not
not
global
global

not
not
not
global
global

not
not
not
global
global

Table 4. Practical identifiability and estimation of parameters when fixing dE , dP , dI , dA , dH , dQ . The symbol
3/ 7 means practically identifiable/not identifiable, respectively. The fitted values will not be counted towards our final
result because the model is not identifiable in this case.
Parameter

Identifiable

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

Stage 6

Stage 7

Î²
p
q

Î´

7
3
3
7
7

0.64
0.39
0.14
1.00
1.00

0.18
0.31
0.37
1.00
0.95

0.32
0.15
0.35
0.05
0.69

0.18
0.12
0.22
0.80
0.63

0.37
0.08
0.13
0.34
0.70

0.19
0.08
0.16
1.00
0.58

0.48
0.08
0.20
0.00
0.71

February 10, 2021

13/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

accurately. When the infectious data are missing, results for the transmission rate Î²
and the hospitalization ratio p cannot be inferred accurately. Non-identifiability of
parameters does not imply the failure of the model. In (VI), we demonstrate that our
model can still be robust and predictable in some cases when it is not identifiable since
the non-identifiable parameters could be insensitive.
The analysis above shows that it would be hard to draw conclusions about the
fitting correctness of transmission rate, proportion of isolated individuals, and
proportion of disease-related deaths when one of the observables considered in this
paper is missing. One of the main differences between the proposed model and most
other existing SEIR-based models is that our model integrates information of infectious,
hospitalized, and deceased populations simultaneously, therefore producing more
reliable results on these estimated parameter values. Since we have data for all three
observables in NYC, we should utilize all of them.
In practice, hospitalization data could be reported in different ways; some databases
provide daily reports of the number of hospitalized individuals, whereas others register
the number of currently hospitalized individuals. Regardless of the data type available,
structurally identifiability of the model remains the same according to S2 Table.

Practical identifiability

410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426

427

We then proceed with fitting 5 undetermined parameters using all the available data,
i.e., Isum , Hsum , and Dsum . The model-fitting techniques, including the loss function
and optimization method, are detailed in the next section. The fitted parameter values
can be found in Table 4. We see that the values of  and Î´ vary a lot among different
stages, which is inconsistent with reality. This poses a question on the practical
identifiability of the model.
The correlation matrices are then computed based on parameters obtained in Stage 1
to help determine the practical identifiability. In practice, one can obtain the correlation
matrix from the FIM of model parameters, with details given in S4 Text. As shown in
Fig 4(b), there is a strong correlation between , Î´, and Î², while either p or q is
uncorrelated with the rest of the parameters. The same phenomenon is observed when
we calculate the correlation matrix based on parameters obtained in other stages; see
S2 Fig. This indicates that , Î´, and Î² are not practically identifiable. Two of them
need to be fixed, while the rest and p, q can be fitted. In this paper, we fix , Î´ and fit
Î², p, q for the following reason: Î², which represents the transmission rate, is highly
affected by local government policy and does not have a stable and universal value
compared to  and Î´. This means that the value of Î² could be very different across
different datasets and is hard to determine a priori. Therefore, we fix  and Î´ according
to [38]. After that, the model becomes practically identifiable as shown in S3 Fig. A
summary of the reasoning is shown in Fig 4(a).

(IV) Sensitivity analysis

428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447

448

Variance-based sensitivity analysis, also called Sobol sensitivity analysis, is a global
method that measures sensitivity across the whole input space. It decomposes the
modelâ€™s output variance into fractions that can be attributed to individual inputs or
groups of inputs [20]. Suppose we are given a black box model:
y = f (Î˜),
where y âˆˆ R is the output and Î˜ = [Î¸1 , Î¸2 , Â· Â· Â· , Î¸k ] âˆˆ [0, 1]k are independent and
uniformly distributed uncertain inputs. If some components of Î˜ are not within [0, 1],
we may transform Î˜ into the unit hypercube.

February 10, 2021

14/39

449
450
451

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 5. Sensitivity of each quantity of interest (Isum , Hsum , Dsum ) with respect to each parameter (Î², p, q).
The parameter Î² is the most important parameter for all three quantities of interest in every stage of the pandemic. The
parameter p has no influence on Isum . The parameter q has no influence on Isum or Hsum .

First-order sensitivity index measures the contribution to the output variance by a
single input Î¸i alone:
VarÎ¸i (EÎ˜âˆ¼i (y|Î¸i ))
Si (y) =
,
Var(y)
where Î˜âˆ¼i = [Î¸1 , Â· Â· Â· , Î¸iâˆ’1 , Î¸i+1 , Â· Â· Â· , Î¸k ]. Total-order sensitivity index measures the
contribution to the output variance by an input, including its first-order effect and all
higher-order interactions with other inputs:
ST i (y) = 1 âˆ’

VarÎ˜âˆ¼i (Exi (y|Î˜âˆ¼i ))
.
Var(y)

452
453
454

(8)

Note that
ST i (y) â‰¥ Si (y)
by definition, and
k
X

ST i (y) â‰¥ 1

i=1

since the interaction between Î¸i and Î¸j is counted in both ST i (y) and ST j (y).
Sensitivity analysis does not rely on any data. Instead, it analyzes the dependence
relationship between the outputs and the inputs of a given model from the level of
parametric equations when a specific initial condition to the system is given. Regarding
the model in Fig 3, the cumulative infectious population Isum in each stage of the
pandemic is a function of the parameters Î², p, and q (they are assumed constant during

February 10, 2021

15/39

455
456
457
458
459
460

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

each period). So are the cumulative hospitalized population Hsum and the cumulative
death population Dsum . Using Sobolâ€™s method, we obtain the first-order sensitivity and
total-order sensitivity of each model output of interest (Isum , Hsum , Dsum ) with
respect to each parameter (Î², p, q). The ranges for Î², p, and q are [0, 1]. For each
model output, 8000 samples are generated using Saltelliâ€™s sampling scheme. The results
are plotted in Fig 5. We can see that the cumulative cases Isum does not depend on p
or q. For the cumulative hospitalizations Hsum , Î² is the most important parameter
while q does not have any impact. For the cumulative deaths Dsum , Î² is the most
influential parameter as well. The qualitative relationship between the scale of
sensitivity indices for different parameters is the same across all stages.
In the proposed model, the parameter Î² is the most important parameter for the
prediction of all Isum , Hsum , and Dsum . Since p and q do not contribute to Isum , our
model may predict Isum even if p and q were inaccurate. Similarly, our model may
predict Hsum even if q were inaccurate.

462
463
464
465
466
467
468
469
470
471
472
473
474

(V) Model calibration

475

Estimation of the number of effective vaccinations

476

The vaccination data of COVID-19 in NYC are given in the form of the number of first
and second doses administered from December 14, 2020 to February 4, 2021 (see Fig 2).
The vaccine efficacy is 52% for only one dose and 95% for both doses. As the vaccines
are not 100% effective, in order to calculate the number of effectively vaccinated
individuals that takes into account the vaccine efficacy, we use a weighted sum of the
number of the first doses and second doses administered:
Effectively vaccinated individuals per day = 0.52 Â· (D1 âˆ’ D2 ) + 0.95 Â· D2 ,

Parameter estimation via simulated annealing

MSE(Inew ) + MSE(Hnew ) + MSE(Dnew )
3

478
479
480
481
482

483
484
485
486
487
488
489
490
491

492

The data of daily cases, hospitalizations, and deaths of COVID-19 in NYC from
February 29, 2020 to February 4, 2021 are given in Fig 2. We assume a constant
population size of 8.399 million people in NYC and do not consider migration. Using
the data with the model in Fig 3, initial values in Table 1, and parameters in Table 2,
we fit the transmission rate Î², hospitalization ratio p, and death from hospital ratio q
within the range [0, 1]. The fitting is split into seven stages defined by the public
policies described in Fig 2. In each stage, the parameters (Î², p, q) are assumed to be
constant as in Eq. (4). We use simulated annealing, a global optimization algorithm, to
search for the optimal parameter values in each stage. The objective is to minimize the
following loss function:
Loss =

477

(9)

where D1 is the number of individuals who receive the first dose and D2 is the number
of individuals who receive the second dose on that day. As the vaccines provide
immunity 14 days after they are received, we remove the effectively vaccinated
individuals from the susceptible (S) class and join them to the recovered (R) class 14
days after they have received the vaccines. To simplify the study, we approximate and
predict the number of daily effective vaccinations linearly with a cap of 17, 500 per day,
which corresponds to a maximum capacity of about 35, 000 total doses per day; see
Fig 6. This approximated and predicted number is used as the time-dependent
parameter v in our model (see Fig 3). Before any vaccine is effective, we have v â‰¡ 0.

February 10, 2021

461

(10)

16/39

493
494
495
496
497
498
499
500
501
502

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 6. Estimation of daily cases, hospitalizations, deaths, and vaccinations in New York City.(a) Estimation of
daily cases. (b) Estimation of daily hospitalizations. (c) Estimation of daily deaths. (d) We calculate the number of effective
vaccinations as a weighted sum of the number of first and second doses administered as shown in Fig 2; we approximate the
daily number of effective vaccinations linearly and assume it grows linearly until it reaches the maximum capacity of 17,500
per day.

Fig 7. Estimation of the unobserved dynamics in all the model compartments (S, E, P , I, A, H, Q, D, R).
The number of susceptible individuals (S) drops significantly as the number of cases hikes after December 2020.

February 10, 2021

17/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 8. Estimation of parameters and reproduction numbers. (a) Estimated time-dependent transmission rate Î²(t).
(b) Estimated time-dependent hospitalization ratio p(t), compared with daily hospitalizations over daily cases calculated from
the raw data. (c) Estimated time-dependent death from hospital ratio q(t), compared with daily deaths over daily
hospitalizations calculated from the raw data. (d) Estimated control reproduction number Rc and effective reproduction
number Re calculated by the estimated parameters, compared with 1/2 of the logarithm of daily cases.
Table 5. Estimation of parameters, control reproduction number, and immunity threshold. The transmission
rate Î² and the control reproduction number Rc change between different stages, indicating that local government policies in
New York City and public holidays have a strong impact on the transmission dynamics of the pandemic.
Î²
p
q
Rc
IT

Meaning

Stage 1

Stage 2

Stage 3

Stage 4

Stage 5

Stage 6

Stage 7

Transmission rate
Hospitalization ratio
Death from hospital ratio
Control reproduction number
Immunity threshold

0.82
0.41
0.15
4.55
78.0%

0.17
0.30
0.37
0.97
0.0%

0.11
0.13
0.35
0.60
0.0%

0.19
0.12
0.22
1.07
6.4%

0.24
0.08
0.13
1.35
26.2%

0.22
0.08
0.17
1.24
19.3%

0.19
0.09
0.20
1.06
5.6%

Table 6. Percentage changes of parameters and control reproduction number between contiguous stages.
The stay-at-home order in Stage 2, mask mandate in Stage 3, closing of indoor dining and starting of vaccination in Stage 6,
and end of the holidays in Stage 7 lead to decreases in the transmission rate Î² and the reproduction number Rc . The
four-phase reopening in Stage 4 and reopening of indoor dining in Stage 5 lead to increases in Î² and Rc .
Î²
p
q
Rc

Meaning

Stage 1â€“2

Stage 2â€“3

Stage 3â€“4

Stage 4â€“5

Stage 5â€“6

Stage 6â€“7

Transmission rate
Hospitalization ratio
Death from hospital ratio
Control reproduction number

âˆ’78.6%
âˆ’26.2%
+150.5%
âˆ’78.6%

âˆ’38.3%
âˆ’55.9%
âˆ’5.3%
âˆ’38.3%

+78.0%
âˆ’10.3%
âˆ’38.0%
+78.0%

+26.8%
âˆ’31.1%
âˆ’40.7%
+26.8%

âˆ’8.6%
âˆ’8.5%
+28.1%
âˆ’8.6%

âˆ’14.5%
+14.5%
+18.9%
âˆ’14.5%

February 10, 2021

18/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

in the region Î², p, q âˆˆ [0, 1], where â€œMSEâ€ stands for mean squared error. The estimated
final value in the previous stage is the initial value for the next stage. The results of all
compartments are plotted in Fig 6 and Fig 7. The time-dependent parameters (Î², p, q)
and the control reproduction number Rc are shown in Fig 8, Table 5, and Table 6.
The control reproduction number Rc , whose expression is in Eq. (5), depends on six
parameters: Î², , Î´, dP , dI , and dA . Since , Î´, dP , dI , and dA are fixed as in Table 2,
Rc is proportional to the transmission rate Î²; see Fig 8. We plot the evolution of Rc
over time and overlay the scaled daily cases to demonstrate how the number of daily
cases and Rc (or Î²) are related to each other. Before any closures took place on March
22, 2020, we had a high Rc with exponential growth of daily cases. Once the strict
control measures were rolled out, Rc was considerably reduced below 1 along with a
decline of daily cases. During the reopening Phases 1â€“4, Rc rose to around 1 with a
stabilized number of daily cases. When indoor dining was reopened on September 30,
2020, Rc rose to above 1 with another wave of daily cases. After indoor dining was
closed again on December 14, 2020, Rc decreased. After the end of holidays, Rc further
decreased.

Bayesian posterior simulation via MCMC

504
505
506
507
508
509
510
511
512
513
514
515
516
517
518

519

We use the loss function Eq. (10) as the negative log-likelihood of the posterior
distribution of the parameters (Î², p, q). We assume that each parameterâ€™s prior
distribution is independent and uniformly distributed in [0, 1]. Using Markov chain
Monte Carlo (MCMC) simulation, we may simulate the posterior distribution of each
parameter associated with our approach. As before, the simulation is done within each
stage where (Î², p, q) are assumed to be constant. In each stage, four chains of 1000
samples are drawn with 200 burn-in samples in every chain. We initialize the chains at
the estimation given by simulated annealing to speed up the algorithm; see S5 Fig â€“
S11 Fig for the posterior distributions and the sampling processes. We can see that the
chains are well-mixed, which implies the convergence of the sampling. The narrow
posterior distributions indicate that our numerical algorithm is robust, the quantity of
data is sufficient for our approach of minimizing the loss function (10), and the
parameters are indeed close to constant in every stage. As a result, the parameter
estimation is reliable.

(VI) Model robustness analysis

520
521
522
523
524
525
526
527
528
529
530
531
532
533

534

Using the fitted parameter values in Table 5, we perform the Monte Carlo simulation to
check the robustness of our model to perturbations, adapting ideas from [19, 57]. The
major difference between their approach and ours is that we incorporate sensitivity
analysis results in our method.
We first multiply the daily increase in the calibrated data (a subset of
{Isum , Hsum , Dsum }) by independent and identically distributed Gaussian random noise
of mean 1 and standard deviation Ïƒ to generate a new dataset, which looks like our
original dataset with measurement error. Then, we estimate the parameters by fitting
the model to the artificially generated dataset and compare the result with the
parameter values obtained in Table 5. The same procedure is repeated for M = 1000
times, and we compute the average error between the parameter values estimated from
the original and the generated datasets. We then rescale this error by a sensitivity
constant, which measures the importance of different parameters on the observables of
interest. The quantity we obtained is named sensitivity-based average relative error

February 10, 2021

503

19/39

535
536
537
538
539
540
541
542
543
544
545
546
547
548

= 0.05

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Isum, Hsum, Dsum

Isum, Hsum

p

p

Isum, Dsum

Hsum, Dsum

Isum

Hsum

Dsum

1

= 0.1

0

1

= 0.2

0

1

0

q

q

p

q

p

q

p

q

p

q

p

q

Fig 9. Sensitivity-based Average Relative Error (SARE) of (Î², p, q) in different observable settings. Each
row corresponds to a standard deviation level of random noise multiplied to the observables. Each column represents an
observable setting. Note that when SARE of a parameter is 0, it means the provided data are not sensitive to that parameter.
When (Isum , Hsum , Dsum ) are given, SARE is lower than the threshold 1. Therefore, our model is robust to noise in the
NYC dataset. In some of the missing observable cases, our model is also robust to perturbations at different noise levels.

(SARE):

549

M
(j)
1 X Î¸Ì‚i âˆ’ Î¸i
SARE(Î¸i ) =
(j)
M Ïƒ j=1
Î¸Ì‚i

r Pm

l=1 ST i (yl )
,
m

(11)

where Î¸i is the fitted value of the ith parameter (i.e., Î², p, q) on the original dataset,
Î¸Ìƒ(j) is the fitted value of the ith parameter on the jth generated dataset, and yl is the
lth observable (i.e. a subset of {Isum , Hsum , Dsum }). The quantity ST i (yl ) defined in
Eq. (8) measures the total contribution to the variance of yl by Î¸i . In other words, it
quantifies the influence of Î¸i on the output variables. For more important parameters
that have a higher ST i , we require more robustness.
When the parameters are piecewise constant and fitted separately, we define the
overall SARE of that parameter to be the largest SARE calculated in every stage. For
example, in this paper, SARE(Î²) = maxsâˆˆ{1,Â·Â·Â· ,7} SARE(Î²s ). Finally, we define the
maximum sensitivity-based average relative error (MSARE) of the model to be the
largest SARE of all the model parameters:
MSARE =

max
iâˆˆ{1,Â·Â·Â· ,k}

SARE(Î¸i ),

551
552
553
554
555
556
557
558
559
560

(12)

where k is the total number of parameters to be estimated. If MSARE < 1, we say the
model is robust to perturbation. The algorithm is detailed in S5 Text. This method is a
complement to the identifiability analysis in the sense that the identifiability analysis
only takes care of the uniqueness of model parameters but not their significance to the
data. An insensitive non-identifiable parameter would not influence the predictability of
the model too much. On the other hand, robustness does not guarantee the correctness

February 10, 2021

550

20/39

561
562
563
564
565
566

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

of the fitted parameters or the inferred compartmental values apart from the particular
data. One has to combine identifiability with robustness to draw conclusions.
The first column in Fig 9 shows that when (Isum , Hsum , Dsum ) are given, our model
is robust to noise, which justifies the correctness of the fitting result (since Î², p, q are
also identifiable) and provides a theoretical backup for the forecasting in the next
section. The other columns in Fig 9 show that even when some observables are missing,
the model could still be robust to perturbation at different noise levels, so that one can
use our model to make predictions in some missing observable cases. For example, only
infectious and hospitalized data (Isum , Hsum ), only hospitalized and deceased data
(Hsum , Dsum ), only infectious data (Isum ), or only hospitalized data (Hsum ) are
available. However, in these scenarios, one should not use the model to infer other
compartments without given data; see S4 Fig. Note that when Dsum is not available,
SARE(q) = 0 because neither Isum nor Hsum is sensitive to q. Similarly, SARE(p) = 0
when only Isum is available since Isum is not sensitive to p.

(VII) Forecasting with uncertainties and scenarios
The situation in NYC evolves day by day. The city reinstated indoor dining restrictions
in mid-December due to the steady increase in the virus incidence. The ever-changing
policies add a high level of uncertainty to any long term forecast we can make. Here, we
explore our modelâ€™s ability to predict the number of daily cases, hospitalizations, and
deaths in the city with uncertainty.
The MCMC simulation provides us with a way to quantify uncertainty. We may
sample from the posterior distribution of the parameters in the last stage (see S11 Fig)
and run the model after that to obtain a distribution of the predicted daily cases,
hospitalizations, and deaths. However, this approach assumes that the situation remains
the same after the last stage, which may not be the case. There might be policy changes
or other events. As a result, we perturb the transmission rate Î² by a percentage to
reflect future policy changes or other events. We sample from the posterior distribution
of the parameters (Î², p, q) in the last stage. Then, we multiply Î² by a random number
drawn from a uniform distribution (U(0.95, 1.05) or U(0.85, 1.15)). In other words, we
perturb Î² by 5% or 15%. As a reference, see Table 6 for the historical changes of Î²
between contiguous stages. We run the model with the initial value as the ending value
of the last stage to predict daily cases, hospitalizations, and deaths. After repeating
4000 times, we obtain a distribution of the daily cases, hospitalizations, and deaths at
every timestamp after the last stage. Then, the 95% confidence interval at every
timestamp is plotted.
In Fig 10, we consider three different scenarios: no indoor dining, reopening indoor
dining on February 14, and reopening indoor dining on March 14. The uncertainties
given by the perturbed Î²â€™s are plotted in each scenario. For indoor dining, we assume it
is a 25% reopening, which is the same as what happened in Stage 5 (September 30, 2020
to December 14, 2020). We multiply Î² by Î²5 /Î²6 to represent the change of the
transmission rate caused by the reopening of indoor dining. An increase in infectious,
hospitalized, and deceased population is expected if the restaurants are reopened.
Postponing the reopening of restaurants from February 14 to March 14 may reduce the
number of infectious, hospitalized, and deceased individuals. The actual situation might
vary depending on the details and implementations of the actual indoor dining policies
that take place in 2021.

February 10, 2021

21/39

567
568
569
570
571
572
573
574
575
576
577
578
579
580

581

582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Fig 10. Forecast of daily cases, hospitalizations, and deaths in New York City with uncertainties and
scenarios. Reopening scenarios on February 14 and March 14 are considered. An increase in infectious, hospitalized, and
deceased population is expected if the restaurants are reopened in the same way as Stage 5 (September 30, 2020 to December
14, 2020). Postponing the reopening of restaurants from February 14 to March 14 may reduce the number of infectious,
hospitalized, and deceased individuals. The actual situation might vary depending on the details and implementations of the
actual indoor dining policies that take place in 2021.

Summary

613

The COVID-19 epidemic is an unprecedented worldwide public health challenge,
especially in densely populated areas such as New York City (NYC). Epidemiological
models can provide the dynamic evolution of a pandemic but they are based on many
assumptions and parameters that have to be adjusted over the time when the pandemic
lasts. However, the available data might not be sufficient to identify the model
parameters and hence infer the unobserved dynamics. This is typical of any past
epidemics or pandemics, and hence a systematic integrated framework is required to
make existing or modified models useful for designing health policies.
To this end and after studying the current pandemic for almost a year, we have
designed a general framework as shown in Fig 1 for building a trustworthy data-driven

February 10, 2021

22/39

614
615
616
617
618
619
620
621
622
623

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

epidemiological model, which constructs a workflow to integrate data acquisition and
event timeline, model development, identifiability analysis, sensitivity analysis, model
calibration, model robustness analysis, and forecasting with uncertainties in different
scenarios. The proposed general framework can provide guidance on how to build the
appropriate epidemiological model based on the available data in a specific region. The
proposed framework can help to assess the structural and practical identifiability of
model parameters so that model parameters can be uniquely estimated, and the
calibrated model can make more robust and reliable predictions that can be used for
evaluating the effect of vaccination and various other scenarios.
In particular, we apply this framework to first endow the SEIR model with more
compartments, and subsequently we extend to include vaccination, with the objective of
forecasting the transmission dynamics of COVID-19 in NYC under vaccination and
different safety measures relaxation scenarios. Based on the proposed general
framework, we first acquire data from the NYCâ€™s governmentâ€™s website and look for
major intervention events that could affect the transmission dynamics of the pandemic.
We then develop a mathematical model that describes the COVID-19 infectionâ€™s
biological characteristics by extending the SEIR model to include presymptomatic,
asymptomatic, isolated, hospitalized, and deceased individuals. This model takes
advantage of all the epidemiological data available from the COVID-19 outbreak in
NYC by fitting hospitalizations and disease-related deaths in addition to the daily cases.
Furthermore, we incorporate the effects of intervention strategies in the outbreakâ€™s
evolution by including time-dependent parameters to capture these variations.
Given a model and epidemiological data, this framework addresses the problem of
identifying which parameters can be inferred accurately. We perform two types of
identifiability analysis, structural identifiability and practical identifiability analysis, to
address this problem. From the structural identifiability analysis, we conclude that five
parameters (Î², p, q, , Î´) of the proposed model are structurally globally identifiable
when daily cases (Inew ), hospitalizations (Hnew ) and deaths (Dnew ) are provided, which
is the case for the NYC dataset. However, when one or two observables are not
available, one cannot get a trustworthy estimation of these parameters since at least one
of the model parameters would be non-identifiable. For the purpose of reliable
parameter estimation, one should utilize all the provided data in NYC.
The Fisher correlation matrix method enables us to determine that two out of five
parameters need to be fixed due to practical non-identifiability, even if all the data
(Inew , Hnew , Dnew ) in the NYC dataset are given. Therefore, we use the values of Î´
and  provided by the CDC pandemic planning scenarios, and once we fix these two
parameters (, Î´), the other three parameters are practically identifiable. For some
other cities, however, it can be challenging to maintain careful records of infected,
hospitalized, and deceased individuals in an ongoing epidemic. The robustness analysis
allows us to conclude that we can still predict some variables with a degree of accuracy
despite missing data since in some cases the non-identifiable parameters are not
sensitive to the model outputs.
As a result, we fit three parameters (Î², p, q) given three observables (Inew , Hnew ,
Dnew ). Sensitivity analysis demonstrates that the parameter Î² is the most important
parameter for the prediction of all Isum , Hsum , and Dsum . Since p and q do not
contribute to Isum , our model may predict Isum even if p and q were inaccurate.
Similarly, our model may predict Hsum even if q were inaccurate.
We observe that the proposed data-driven epidemiological model can uniquely
estimate the model parameters, and the predicted daily cases, hospitalizations, and
deaths match well with the available data from NYCâ€™s governmentâ€™s website. In
addition, we employ Monte Carlo simulations to quantify the uncertainties in the
parameters and forecast under uncertainties. We employ the calibrated data-driven

February 10, 2021

23/39

624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

model to study the effects of the timing of reopening indoor dining. The prediction
results indicate that postponing the reopening of restaurants from February 14 to
March 14 may reduce the number of infectious, hospitalized, and deceased individuals.
Such forecasts can be readily be updated as new data are accumulated. The actual
situation might vary depending on the details and implementations of the actual indoor
dining policies that take place in 2021 and corresponding updates are required.

677
678
679
680
681

Acknowledgments

682

We gratefully acknowledge the support from ARO/MURI grant W911NF-15-1-0562.

683

Author contributions

684

Conceptualization: Sheng Zhang, Joan Ponce, Guang Lin, George Karniadakis

685

Data curation: Sheng Zhang

686

Formal analysis: Sheng Zhang, Zhen Zhang

687

Funding acquisition: Guang Lin, George Karniadakis

688

Investigation: Sheng Zhang, Joan Ponce, Zhen Zhang

689

Methodology: Sheng Zhang, Joan Ponce, Zhen Zhang

690

Project administration: Sheng Zhang, Joan Ponce, Guang Lin, George Karniadakis

691

Resources: N/A

692

Software: Sheng Zhang, Zhen Zhang

693

Supervision: Guang Lin, George Karniadakis

694

Validation: Sheng Zhang, Zhen Zhang

695

Visualization: Sheng Zhang, Zhen Zhang

696

Writing â€” original draft preparation: Sheng Zhang, Joan Ponce, Zhen Zhang

697

Writing â€” review & editing: Sheng Zhang, Joan Ponce, Zhen Zhang, Guang Lin,
George Karniadakis

References

698
699

700

1. Zheng W. Total Variation Regularization for Compartmental Epidemic Models
with Time-varying Dynamics. arXiv preprint arXiv:200400412. 2020; p. 1â€“11.
2. Roda WC, Varughese MB, Han D, Li MY. Why is it difficult to accurately
predict the COVID-19 epidemic? Infectious Disease Modelling. 2020;5:271â€“281.
3. Lourenco J, Paton R, Ghafari M, Kraemer M, Thompson C, Simmonds P, et al.
Fundamental principles of epidemic spread highlight the immediate need for
large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic.
MedRxiv. 2020; p. 1â€“7.
4. Maier BF, Brockmann D. Effective containment explains subexponential growth
in recent confirmed COVID-19 cases in China. Science. 2020;368(6492):742â€“746.

February 10, 2021

676

24/39

701
702

703
704

705
706
707
708

709
710

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

5. Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, et al.
Modelling the COVID-19 epidemic and implementation of population-wide
interventions in Italy. Nature Medicine. 2020; p. 1â€“6.
6. Gaeta G. A simple SIR model with a large set of asymptomatic infectives. arXiv
preprint arXiv:200308720. 2020; p. 1â€“23.
7. Shi P, Cao S, Feng P. SEIR Transmission dynamics model of 2019 nCoV
coronavirus with considering the weak infectious ability and changes in latency
duration. MedRxiv. 2020; p. 1â€“5.
8. Zha Wt, Pang Fr, Zhou N, Wu B, Liu Y, Du Yb, et al. Research about the
optimal strategies for prevention and control of varicella outbreak in a school in a
central city of China: Based on an SEIR dynamic model. Epidemiology &
Infection. 2020;148.
9. He S, Peng Y, Sun K. SEIR modeling of the COVID-19 and its dynamics.
Nonlinear Dynamics. 2020;101(3):1667â€“1680.

712
713

714
715

716
717
718

719
720
721
722

723
724

10. LoÌpez L, Rodo X. A modified SEIR model to predict the COVID-19 outbreak in
Spain and Italy: simulating control scenarios and multi-scale epidemics. Results
in Physics. 2021;21:103746.
11. Yang Z, Zeng Z, Wang K, Wong SS, Liang W, Zanin M, et al. Modified SEIR
and AI prediction of the epidemics trend of COVID-19 in China under public
health interventions. Journal of Thoracic Disease. 2020;12(3):165.
12. Wang H, Yamamoto N. Using a partial differential equation with Google Mobility
data to predict COVID-19 in Arizona. Mathematical Biosciences and Engineering.
2020;17(5).
13. Viguerie A, Lorenzo G, Auricchio F, Baroli D, Hughes TJ, Patton A, et al.
Simulating the spread of COVID-19 via a spatially-resolved
susceptibleâ€“exposedâ€“infectedâ€“recoveredâ€“deceased (SEIRD) model with
heterogeneous diffusion. Applied Mathematics Letters. 2021;111:106617.
14. Rodriguez-Fernandez M, Mendes P, Banga JR. A hybrid approach for efficient
and robust parameter estimation in biochemical pathways. Biosystems.
2006;83(2-3):248â€“265.
15. Rodriguez-Fernandez M, Egea JA, Banga JR. Novel metaheuristic for parameter
estimation in nonlinear dynamic biological systems. BMC bioinformatics.
2006;7(1):483.
16. Massonis G, Banga JR, Villaverde AF. Structural identifiability and observability
of compartmental models of the COVID-19 pandemic. Annual reviews in control.
2020; p. 1â€“19.
17. Gallo L, Frasca M, Latora V, Russo G. Lack of practical identifiability may
hamper reliable predictions in COVID-19 epidemic models. arXiv preprint
arXiv:201200443. 2020; p. 1â€“33.
18. Lee C, Li Y, Kim J. The susceptible-unidentified infected-confirmed (SUC)
epidemic model for estimating unidentified infected population for COVID-19.
Chaos, Solitons & Fractals. 2020;139:110090.
19. Tuncer N, Le TT. Structural and practical identifiability analysis of outbreak
models. Mathematical biosciences. 2018;299:1â€“18.

February 10, 2021

711

25/39

725
726
727

728
729
730

731
732
733

734
735
736
737

738
739
740

741
742
743

744
745
746

747
748
749

750
751
752

753
754

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

20. Sobol IM. Global sensitivity indices for nonlinear mathematical models and their
Monte Carlo estimates. Mathematics and computers in simulation.
2001;55(1-3):271â€“280.
21. WHO. Coronavirus disease 2019 (COVID-19) Situation Report â€“ 51; 2020.
https://apps.who.int/iris/bitstream/handle/10665/331475/
nCoVsitrep11Mar2020-eng.pdf?sequence=1&isAllowed=y.
22. Yan H, Sgueglia K. New Yorkâ€™s first case of coronavirus is a health care worker,
and officials say more cases are â€˜inevitableâ€™; 2020. Available from:
https://edition.cnn.com/2020/03/02/us/new-york-coronavirus-firstcase/index.htm.
23. West MG. First Case of Coronavirus Confirmed in New York State; 2020.
Available from: https://www.wsj.com/articles/first-case-ofcoronavirus-confirmed-in-new-york-state-11583111692.

756
757

758
759
760

761
762
763
764

765
766
767

24. Governor A M Cuomo. Governor Cuomo Signs the â€™New York State on PAUSEâ€™
Executive Order; 2020. https://www.governor.ny.gov/news/governor-cuomosigns-new-york-state-pause-executive-order.
25. NYC Health Department. NYC Coronavirus Disease 2019 (COVID-19) Data;
2020. https://github.com/nychealth/coronavirus-data#nyc-coronavirusdisease-2019-covid-19-data.
26. Holmdahl I, Buckee C. Wrong but usefulâ€”what covid-19 epidemiologic models
can and cannot tell us. New England Journal of Medicine. 2020;383(4):303â€“305.
27. Governor A M Cuomo. At Novel Coronavirus Briefing, Governor Cuomo Declares
State of Emergency to Contain Spread of Virus; 2020.
https://www.governor.ny.gov/news/novel-coronavirus-briefinggovernor-cuomo-declares-state-emergency-contain-spread-virus.
28. Governor A M Cuomo. Amid Ongoing COVID-19 Pandemic, Governor Cuomo
Issues Executive Order Requiring All People in New York to Wear Masks or Face
Coverings in Public; 2020.
https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemicgovernor-cuomo-issues-executive-order-requiring-all-people-new.
29. CDC. Considerations for Wearing Masks: Help Slow the Spread of COVID-19;
2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-gettingsick/cloth-face-cover-guidance.html(03-April-2020).
30. Governor A M Cuomo. NY Forward: A Guide to Reopening New York &
Building Back Better; 2020. https://www.governor.ny.gov/sites/
governor.ny.gov/files/atoms/files/NYForwardReopeningGuide.pdf.

768
769
770

771
772
773

774
775

776
777
778
779

780
781
782
783
784

785
786
787

788
789
790

31. New York State Government. Phase One Industry; 2020.
https://forward.ny.gov/phase-one-industries.

791
792

32. New York State Government. Phase Two Industry; 2020.
https://forward.ny.gov/phase-two-industries.

793
794

33. Andrew S, Myles M. NYC Indoor Dining to Resume Sept. 30 With Heavy
Restrictions, Cuomo Says; 2020.
https://www.nbcnewyork.com/news/local/nyc-casinos-malls-reopentoday-cuomo-and-de-blasio-face-lawsuit-over-indoor-dining/2607750.

February 10, 2021

755

26/39

795
796
797
798

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

34. Gold M. Indoor Dining Will Shut Down in New York City Again; 2020.
https://www.nytimes.com/2020/12/11/nyregion/indoor-dining-nyc.html.
35. Luis FS, Joseph G. 1st Vaccination in U.S. Is Given in New York, Hard Hit in
Outbreakâ€™s First Days; 2020. https://www.nytimes.com/2020/12/14/
nyregion/coronavirus-vaccine-new-york.html.
36. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al.
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England
Journal of Medicine. 2020;383(27):2603â€“2615.
37. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy
and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of
Medicine. 2020; p. 403â€“416.
38. CDC. COVID-19 Pandemic Planning Scenarios; 2020. https:
//www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html(10July-2020).
39. Hao X, Cheng S, Wu D, Wu T, Lin X, Wang C. Reconstruction of the full
transmission dynamics of COVID-19 in Wuhan. Nature. 2020;584(7821):420â€“424.
40. Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH, et al. Contact tracing
assessment of COVID-19 transmission dynamics in Taiwan and risk at different
exposure periods before and after symptom onset. JAMA internal medicine.
2020;180(9):1156â€“1163.
41. Byambasuren O, Cardona M, Bell K, Clark J, McLaws ML, Glasziou P.
Estimating the extent of true asymptomatic COVID-19 and its potential for
community transmission: systematic review and meta-analysis. Available at
SSRN 3586675. 2020; p. 1â€“14.
42. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic
proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond
Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance.
2020;25(10):2000180.
43. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic
carrier transmission of COVID-19. Jama. 2020;323(14):1406â€“1407.
44. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung Sm, Hayashi K, et al.
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).
International journal of infectious diseases. 2020;94:154.
45. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic
and international spread of the 2019-nCoV outbreak originating in Wuhan, China:
a modelling study. The Lancet. 2020;395(10225):689â€“697.
46. Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe
acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic.
Emerging infectious diseases. 2020;26(7).
47. Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, et al.
Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a
long-term care skilled nursing facilityâ€”King County, Washington, March 2020.
Morbidity and Mortality Weekly Report. 2020;69(13):377.

February 10, 2021

27/39

799
800

801
802
803

804
805
806

807
808
809

810
811
812

813
814

815
816
817
818

819
820
821
822

823
824
825
826

827
828

829
830
831

832
833
834

835
836
837

838
839
840
841

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

48. Anderson RM, May RM. The population dynamics of microparasites and their
invertebrate hosts. Philosophical Transactions of the Royal Society of London B,
Biological Sciences. 1981;291(1054):451â€“524.
49. Horwitz L, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, et al. Trends in
Covid-19 risk-adjusted mortality rates in a single health system. medRxiv. 2020;
p. 1â€“5.
50. Petrilli CM, Jones SA, Yang J, Rajagopalan H, Oâ€™Donnell LF, Chernyak Y, et al.
Factors associated with hospitalization and critical illness among 4,103 patients
with COVID-19 disease in New York City. MedRxiv. 2020; p. 1â€“25.
51. Bellman R, AÌŠstroÌˆm KJ. On structural identifiability. Mathematical biosciences.
1970;7(3-4):329â€“339.
52. Rothenberg TJ. Identification in parametric models. Econometrica: Journal of
the Econometric Society. 1971; p. 577â€“591.
53. Glover K, Willems J. Parametrizations of linear dynamical systems: Canonical
forms and identifiability. IEEE Transactions on Automatic Control.
1974;19(6):640â€“646.
54. Thowsen A. Identifiability of dynamic systems. International Journal of Systems
Science. 1978;9(7):813â€“825.
55. Reid J. Structural identifiability in linear time-invariant systems. IEEE
Transactions on Automatic Control. 1977;22(2):242â€“246.

843
844

845
846
847

848
849
850

851
852

853
854

855
856
857

858
859

860
861

56. Hong H, Ovchinnikov A, Pogudin G, Yap C. SIAN: software for structural
identifiability analysis of ODE models. Bioinformatics. 2019;35(16):2873â€“2874.
57. Miao H, Xia X, Perelson AS, Wu H. On identifiability of nonlinear ODE models
and applications in viral dynamics. SIAM review. 2011;53(1):3â€“39.
58. CDC. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization
Surveillance Network (COVID-NET); 2020. https://www.cdc.gov/coronavirus/
2019-ncov/covid-data/covid-net/purpose-methods.html(28-Aug-2020).
59. Diekmann O, Heesterbeek JAP, Metz JAJ. On the definition and the
computation of the basic reproduction ratio R0 in models for infectious diseases
in heterogeneous populations. Journal of Mathematical Biology.
1990;28(4):365â€“382. doi:10.1007/BF00178324.
60. Hong H, Ovchinnikov A, Pogudin G, Yap C. Global identifiability of differential
models. Communications on Pure and Applied Mathematics.
2020;73(9):1831â€“1879.
61. Rao CR. Information and the accuracy attainable in the estimation of statistical
parameters. Reson J Sci Educ. 1945;20:78â€“90.

February 10, 2021

842

28/39

862
863

864
865

866
867
868

869
870
871
872

873
874
875

876
877

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Supporting information

878

S1 Text. Model development. We adopt the following step-by-step procedure to
build our model:
1. Choose components of the dynamics to simulate the transmission of the disease:
susceptible (S), exposed (E), presymptomatic (P ), symptomatic (I),
asymptomatic (A), hospitalized (H), isolated (Q), deceased (D), and
recovered (R).
2. Identify the flow between the components and link them with directed arrows.
Assign the rate of the flow with one parameter per arrow except for S â†’ E, which
is defined by the transmission of the disease. See S1 Fig.
3. Change parameters such that every parameter has physical meaning. We use nine
parameters (p, q, Î´, dE , dP , dI , dA , dH , dQ ) to replace (w1 , Â· Â· Â· , w9 ). See Eq. (13)
for the formulas. Note that there is a one-to-one correspondence between the nine
parameters we use and (w1 , Â· Â· Â· , w9 ).
4. Add vaccination dynamics S â†’ R.
ï£±
dE = w 1
ï£´
ï£´
ï£´
ï£´
ï£´
dP = w2 + w3
ï£´
ï£´
ï£´
ï£´
w2
ï£´
ï£´
Î´=
ï£´
ï£´
w2 + w3
ï£´
ï£´
ï£´
ï£´
ï£´
d
=
w
I
4 + w5
ï£´
ï£´
ï£²
w4
p=
w4 + w5
ï£´
ï£´
ï£´
ï£´
ï£´
d
=
w
A
6
ï£´
ï£´
ï£´
ï£´
ï£´
dH = w7 + w8
ï£´
ï£´
ï£´
ï£´
w7
ï£´
ï£´
ï£´
ï£´ q = w7 + w8
ï£´
ï£´
ï£³
dQ = w9

ï£±
w1
ï£´
ï£´
ï£´
ï£´
ï£´
w2
ï£´
ï£´
ï£´
ï£´
ï£´
w3
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²w4
w5
ï£´
ï£´
ï£´
w6
ï£´
ï£´
ï£´
ï£´
ï£´
w7
ï£´
ï£´
ï£´
ï£´
ï£´
w8
ï£´
ï£´
ï£´
ï£³
w9

= dE
= Î´dP
= (1 âˆ’ Î´)dP
= pdI
= (1 âˆ’ p)dI
= dA
= qdH
= (1 âˆ’ q)dH
= dQ

(13)

S2 Text. Parameter settings. Parameter values for the fixed parameters are
summarized in Table 2. The percentage of infected people who never show the diseaseâ€™s
symptoms is extracted from the CDCâ€™s current best estimate for this value [38]. The
parameter Î´ is obtained by averaging the lower and upper bounds of the estimates for
this value from different sources:
0.3 + 0.9
= 0.6.
2

We use data from the hospitalization surveillance network used by the CDC to estimate
the median number of days an individual spends hospitalized due to the disease [58].
The numbers provided are specific to individuals admitted to the ICU and not admitted
to the ICU divided into age groups; therefore, we perform a weighted average of those
values considering the demographic composition of NYC. According to S1 Table, the
average number of days of hospitalization for individuals aged 18-49 years is:
3 Ã— (1 âˆ’ 0.238) + 11 Ã— 0.238 = 4.904;
average number of days of hospitalization for individuals aged 50-64 years:
4 Ã— 0.639 + 14 Ã— 0.361 = 7.610;

February 10, 2021

880

881
882
883
884

885
886
887

888
889
890
891

892

â‡â‡’

Î´=

879

29/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

average number of days of hospitalization for individuals aged â‰¥ 65 years:
6 Ã— 0.647 + 12 Ã— 0.353 = 8.118.
As a result, the total average number of days of hospitalization dH for all age groups
can be obtained in the following way:
dH â‰ˆ

4.904 + 7.610 + 8.118
â‰ˆ 6.9.
3

S3 Text. Basic and control reproduction number of the model in Fig 3.
The reproduction number in Eq. (5) is obtained using the next generation matrix
operator described in [59]. The vector of infected state variables
i considering
h without
âˆ‚Fi (x0 )
and
hospitalization is denoted by x = (E, P, I, A). We define F =
âˆ‚xj
h
i
âˆ‚Vi (x0 )
V =
, where Fi is the rate of appearance of new infections in the ith
âˆ‚xj
compartment; Vi = Viâˆ’ âˆ’ Vi+ , where Vi+ is the rate of transfer of individuals into the
ith compartment by all other means except for infection, and Viâˆ’ is the rate of transfer
of individuals out of the ith compartment; and
x0 = (S := 1, E := 0, P := 0, I := 0, A := 0, H := 0, Q := 0, D := 0, R := 0)
is the diseaseâ€“free
ï£«
0
ï£¬ 0
F =ï£¬
ï£­ 0
0

equilibrium state of the system. We have
ï£¶
ï£«
Î² Î² Î²
dE
0
ï£¬ âˆ’dE
0 0 0 ï£·
d
P
ï£· and V = ï£¬
ï£­ 0
0 0 0 ï£¸
âˆ’dP Î´
0 0 0
0
âˆ’dP (1 âˆ’ Î´)

0
0
dI
0

ï£¶
0
0 ï£·
ï£·.
0 ï£¸
dA

Then,
ï£«

Î²



(dA âˆ’Î´dP +dP )
dA dP

ï£¬
ï£¬
F V âˆ’1 = ï£¬
ï£­

0
0
0

+

Î´
dI



Î²



(dA âˆ’Î´dP +dP )
dA dP

+

Î´
dI



0
0
0

Î²
dI

0
0
0

Î²
dA

ï£¶

ï£·
0 ï£·
ï£·.
0 ï£¸
0

Let Ï(F V âˆ’1 ) denote the dominant eigenvalue of F V âˆ’1 . The control reproduction
number is given by Rc = Ï(F V âˆ’1 ).

893
894

S4 Text. Definition and algorithm for identifiability analysis.

895

Structural identifiability

896

Suppose we are give a dynamical system of the following abstract form

897

dX
= f (X(t), Î˜, u(t))
dt
y(t) = g(X(t), Î˜, u(t)),

(14)

where X = (X1 , Â· Â· Â· , Xn ) represents the state variables, y = (y1 , Â· Â· Â· , ym ) represents the
observables, Î˜ = (Î¸1 , Â· Â· Â· , Î¸k ) contains the parameters to identify, and u(t) represents
the input variable to the system. A parameter set Î˜ is called structurally identifiable if
g(X(t), Î˜, u(t)) = g(X(t), Î¦, u(t)) =â‡’ Î˜ = Î¦

February 10, 2021

(15)

30/39

898
899
900

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

for every Î¦ = (Ï†1 , Â· Â· Â· , Ï†k ) in the same space as Î˜. A single parameter Î¸i âˆˆ Î˜ is called
structurally identifiable if
g(X(t), Î˜, u(t)) = g(X(t), Î¦, u(t)) =â‡’ Î¸i = Ï†i .

Practical identifiability and correlation matrix

903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924

925

A parameter is called practically identifiable if it can be uniquely determined from the
discrete data points instead of the structure of the equation. A structurally identifiable
parameter may not be practically identifiable given the noise and limited measure
points in the data. Unlike structural identifiability, there is no consistent definition of
practical identifiability in the literature. Nevertheless, several methods including
correlation matrix methods have been proposed to describe practical identifiability
quantitatively [19, 57].
Statistical correlation can be used to describe some of the practical
non-identifiability phenomena. Specifically, one can use the Fisher Information Matrix
(FIM) to calculate the correlation matrix of Î˜ in Eq. (14). FIM is defined as:
T
X

902

(16)

The structural identifiability, defined above, is referred to as global identifiability
in [51â€“54]. Global identifiability is stronger than the so-called local identifiability, which
only requires Eq. (15) or Eq. (16) to hold in a neighbourhood N (Î˜) of Î˜. Structural
identifiability analysis is usually conducted before the fitting of the model and it does
not rely on any data.
We perform the structural identifiability analysis using the software SIAN [56],
which is based on differential algebra and Taylor series expansion. Detailed
documentations on the theory behind the software can be found in [60], and information
regarding the algorithm can be obtained from [56].
SIAN is a randomized algorithm that requires users to choose a hyperparameter that
defines the probability of correctness. In this paper we choose 0.999. The algorithm first
replaces the observables with their truncated Taylor series and reduces the identifiability
problem to the problem of studying the generic fiber of the map between the parameter
space and the space of truncated observables, which is a map between finite-dimensional
varieties. Due to the hardness of analyzing the generic fiber, a step to simplify
computation is applied in the algorithm by studying fiber at a specific point instead of
generic ones. The correctness of this step is controlled by the hyperparameter
aforementioned. The problem is then turned into checking the consistency of a system of
algebraic equations. The Buchberger algorithm allows the computation of the Grobner
basis of the system. This basis shows whether the algebraic relationsâ€™ parameters have a
single solution/finitely many solutions/infinitely many solutions, which implies the
model would be structurally globally identifiable/locally identifiable/not identifiable.

F =

901

926
927
928
929
930
931
932

SiT V âˆ’1 Si ,

i=1
i)
where V is covariance matrix of the measurements error. Si = âˆ‚ yÌƒ(t
âˆ‚Î˜ is the sensitivity
matrix at time ti , which can be calculated by solving the adjoint equation:

âˆ‚g(X(Â·), Î˜)
âˆ‚g(X(Â·), Î˜)
dSi
=
(ti ) Si +
(ti )
dt
âˆ‚X
âˆ‚Î˜
using automatic differentiation libraries. It is proved that the correlation matrix is equal
to F âˆ’1 by the CrameÌrâ€“Rao theorem [61]. Once the correlation matrix is obtained, one
can determine whether a parameter is identifiable by checking whether it is correlated
with the other parameters. If Î¸i is strongly correlated with Î¸j , then neither of these
parameters is practically identifiable because they cannot be uniquely determined from
the data.

February 10, 2021

31/39

933
934
935
936
937
938

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S5 Text. Definition and algorithm for model robustness. The procedure of
Monte Carlo simulation for model robustness can be summarized into the following
steps:
â€¢ Solve Eq. (14) with Î˜ equal to the estimated value Î˜Ìƒ to get the calibrated
observables yÌƒ at the time stamps where the original data are sampled. For
example, for NYC dataset in the fully-observed case, we assume
yÌƒ = [Inew , Hnew , Dnew ], i.e., the daily increase in Isum , Hsum , and Dsum .

939
940
941

942
943
944
945

â€¢ Multiply the calibrated observables yÌƒi by independent and identically distributed
(j)
Gaussian random noise Î¾i âˆ¼ N (1, Ïƒ 2 IT ), 1 â‰¤ i â‰¤ m, 1 â‰¤ j â‰¤ M , where T is the
number of time stamps, IT is the T Ã— T identity matrix, and M is the number of
Monte Carlo steps. By this method we generate a dataset of size M :
[Y (1) , Â· Â· Â· , Y (M ) ] = [yÌƒ
where

Î¾ (1) , Â· Â· Â· , yÌƒ

Î¾ (M ) ],

(j)

(j)

is the elementwise product and Î¾ (j) = [Î¾1 , Â· Â· Â· , Î¾m ].

946

â€¢ The parameters are estimated again using these perturbed observables {Y (j) }M
j=1 .
The estimated value for the ith unknown parameter Î¸i using Y (j) is denoted as
(j)
Î¸Ë†i . The sensitivity-based average relative error (SARE) for Î¸i is defined as:
(j)
M
1 X Î¸Ë†i âˆ’ Î¸i
SARE(Î¸i ) =
(j)
M Ïƒ j=1
Î¸Ì‚i

r Pm

l=1

ST i (yl )
,
m

where ST i (yl ) is the total-order sensitivity, which is the contribution to the
variance of yl by Î¸i . In other words, it quantifies the influence of Î¸i on the output
variable. For more important parameters which have a higherqST i , we require
Pm

S

(y )

l
l=1 T i
more robustness. This is taken into account by the multiplier
in the
m
definition of SARE. Finally, we define the maximum sensitivity-based average
relative error (MSARE) of the model to be the largest SARE across all the model
parameters:
MSARE = max SARE(Î¸i ).

iâˆˆ{1,Â·Â·Â· ,k}

If MSARE < 1, we say that the model is robust to perturbation.

947

S1 Table. Data to estimate dH .

948

S2 Table. Structural identifiability of the model with H as an observable.
Different from Table 3, we assume H instead of Hsum is observed as data.

950

S1 Fig. Raw model.

951

S2 Fig. Correlation matrix of Î², p, q, Î´, and  in different stages.

952

S3 Fig. Correlation matrix of Î², p, and q in the setting of different
observables.

953
954

S4 Fig. Fitting and prediction with the data given as (Inew , Hnew ),
(Hnew , Dnew ), or (Inew ).

955
956

S5 Fig. MCMC simulation in Stage 1.

February 10, 2021

949

957

32/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S1 Table. Data from CDC website (COVID-19 Pandemic Planning Scenarios) to estimate dH .
Median number of days of hospitalization among those not admitted to ICU
Median number of days of hospitalization among those admitted to ICU
Percent admitted to ICU among those hospitalized

18-49 years

50-64 years

â‰¥ 65 years

3
11
23.8%

4
14
36.1%

6
12
35.3%

S2 Table. Structural identifiability of the model with H as an observable. Structural identifiability is tested when
H instead of Hsum is given as an observable. It turns out that the identifiability result is similar to Table 3.
Parameter

Isum , H, Dsum

Isum , H

H, Dsum

H

Î²
p
q

Î´

global
global
global
global
global

global
global
not
global
global

not
not
global
global
global

not
not
not
global
global

S1 Fig. Raw model. The graph demonstrates an intermediate step of building the proposed model in Fig 3. It has the
same compartmental structure as the final model but the inflows and outflows of different compartments are parameterized by
unknown wi â€™s. It can be transformed to the final model through a change of variable in Eq. (13) and a supplement of
vaccination dynamics.

February 10, 2021

33/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Stage 2

Stage 3

Stage 4

Stage 5

Stage 6

Stage 7

p
q

p
q

p
q

p
q

p
q

1.00
0.75
0.50
0.25
0.00
0.25
0.50
0.75
1.00

S2 Fig. Correlation matrix of Î², p, q, Î´, and  in Stage 2 to Stage 7. Green means (almost) not statistically
correlated while yellow/purple represents positively/negatively correlated. The correlation matrices are similar in theses
stages, i.e., there is always correlation between Î², , Î´ while there is no correlation between p, q and the other parameters.

Isum, Hsum, Dsum

Isum, Hsum

Isum, Dsum

Hsum, Dsum

Isum

Hsum

p
q

p

q

p

q

p

q

p

q

1.00
0.75
0.50
0.25
0.00
0.25
0.50
0.75
1.00

S3 Fig. The correlation matrix of Î², p, and q in the setting of different observables, calculated in Stage 1.
Green means (almost) not statistically correlated while yellow/purple represents positively/negatively correlated. When Isum ,
Hsum , and Dsum are available, the model is practically identifiable. In other cases, there is correlation between the
parameters.

February 10, 2021

34/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S4 Fig. Fitting and prediction with the data given as (Inew , Hnew ), (Hnew , Dnew ), or (Inew ). Other settings are the
same as Fig 6. Each row represents the fitting and prediction of an observable. Each column represents an observable setting.
When only Inew and Hnew are available, the fitting and prediction for Dnew is inaccurate, while the fitting and prediction for
Inew and Hnew are correct. When only Hnew and Dnew are available, the fitting and prediction for Inew is inaccurate, while
the fitting and prediction for Hnew and Dnew are correct. When only Inew is given, the model can only predict Inew correctly.
These results can be explained by model robustness analysis.

February 10, 2021

35/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S5 Fig. MCMC simulation in Stage 1. Four chains of 1000 samples are drawn with 200 burn-in samples in every chain.
[Left Column] Posterior distributions of the parameters (Î², p, q). The narrow posterior distributions indicate that our
numerical algorithm is robust, the quantity of data is sufficient for our approach of minimizing the loss function Eq. (10), and
the parameters are indeed close to constant. [Right Column] Sampling processes of the parameters. We can see that the
chains are well-mixed, which implies the convergence of the sampling.

S6 Fig. MCMC simulation in Stage 2. Other settings are the same as S5 Fig.

February 10, 2021

36/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

February 10, 2021

S6 Fig. MCMC simulation in Stage 2.

958

S7 Fig. MCMC simulation in Stage 3.

959

S8 Fig. MCMC simulation in Stage 4.

960

S9 Fig. MCMC simulation in Stage 5.

961

S10 Fig. MCMC simulation in Stage 6.

962

S11 Fig. MCMC simulation in Stage 7.

963

37/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S7 Fig. MCMC simulation in Stage 3. Other settings are the same as S5 Fig.

S8 Fig. MCMC simulation in Stage 4. Other settings are the same as S5 Fig.

S9 Fig. MCMC simulation in Stage 5. Other settings are the same as S5 Fig.

February 10, 2021

38/39

medRxiv preprint doi: https://doi.org/10.1101/2021.02.22.21252255; this version posted February 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

S10 Fig. MCMC simulation in Stage 6. Other settings are the same as S5 Fig.

S11 Fig. MCMC simulation in Stage 7. Other settings are the same as S5 Fig.

February 10, 2021

39/39

